SCHEMBL23901595

SCHEMBL23901595

Cc1cc(-c2cccnc2)nc2c(C(=O)NCCC3CCC(c4ccco4)CC3)ncn12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 1/20 0.38
CRHR2 Q13324 1/20 0.38
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPK1 P28482 1/20 0.35
CHRM4 P08173 1/20 0.35
NAMPT P43490 1/20 0.35
ADORA2A P29274 1/20 0.35
TP53 P04637 1/20 0.34
DYRK1A Q13627 2/20 0.34
TYRO3 Q06418 1/20 0.34
DRD2 P14416 1/20 0.34
HTR2A P28223 1/20 0.34
DRD3 P35462 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
VCP P55072 1/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23901682 0.91 CRHR1 (0.44) CRHR1CRHR2CHRM4NAMPTADORA2A
SCHEMBL22472764 0.86 SCD (0.37) KDM4EALDH1A1MAPK1CHRM4DRD2
SCHEMBL24080652 0.84 ALDH1A1 (0.46) KDM4EALDH1A1MAPK1TP53MEN1
SCHEMBL22472761 0.84 TSHR (0.36) ALDH1A1MAPK1MEN1TSHRKMT2A
SCHEMBL23901680 0.82 POLB (0.41) CRHR1CRHR2CHRM4TP53DYRK1A
SCHEMBL19449370 0.78 CRHR1 (0.41) CRHR1CRHR2KDM4EALDH1A1MAPK1
SCHEMBL22472752 0.78 RIPK1 (0.37) KDM4EALDH1A1KMT2AHSD17B10
SCHEMBL23901594 0.77 ALDH1A1 (0.42) KDM4EALDH1A1MAPK1NAMPTADORA2A
SCHEMBL19449422 0.77 DYRK1A (0.49) CRHR1CRHR2KDM4EALDH1A1DYRK1A
SCHEMBL21483516 0.76 CRHR1 (0.44) CRHR1CRHR2KDM4EALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210309661-A1 IMIDAZO[1,5-a]PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS BIAL - R&D INVESTMENTS, S.A. (PT) 2021-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210309661-A1 IMIDAZO[1,5-a]PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS GBA1, GAA, GBA2 CRHR1 3609/4885CRHR2 3728/4885KDM4E 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.